Biomarin Pharmaceutical Inc annual earnings per share (EPS) for fiscal TTM was $0.36, a decrease of 79.7% from $1.77 in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| EPS (annual) | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (EPS) | $0.36 | $1.77 | $2.17 | $0.87 | $0.75 | $-0.35 | $4.46 | $-0.13 | $-0.44 | $-0.67 | $-3.79 | $-1.07 | $-0.92 | $-1.28 | $-0.95 | $-0.48 | $1.64 | $-0.00 | $0.30 | $-0.16 | $-0.34 |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| EPS (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (EPS) | $0.23 | $0.53 | $-0.24 | $-0.16 | $1.22 | $0.95 | $0.64 | $0.54 | $0.53 |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More BMRN metrics: Revenue · Gross Profit · Operating Income · Net Income · EBITDA · Free Cash Flow · Shares Outstanding
All BMRN financial statements → Interactive BMRN charts →
About TickerBase · Data methodology & sources · Privacy · Terms